Physicians are criticizing the government's distribution of remdesivir, Gilead's drug that received emergency authorization from the FDA May 1 to treat COVID-19, saying the government isn't prioritizing the hospitals that need the drug most, STAT reported.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,